Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Funding
Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake in MiRus worth approximately 34%. The deal also includes an...

Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Funding
Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake...

EmStop initiates IDE study of novel embolic protection device

Clinical Trials
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Butterfly Medical raises $21M for Benign Prostatic Hyperplasia device

Funding
Butterfly Medical announced that it completed its Series C funding round, bringing in $21 million to support its BPH treatment. The company develops the Butterfly...

NVision raises $55M to expand from quantum MRI

Funding
NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

CVRx enrolls first patient in study of Barostim therapy for heart failure

CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

Innovation

Regulatory Approvals

Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake...

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Butterfly Medical raises $21M for Benign Prostatic Hyperplasia device

Butterfly Medical announced that it completed its Series C funding round, bringing in $21 million to support its BPH treatment. The company develops the Butterfly...

NVision raises $55M to expand from quantum MRI

NVision has raised $55 million in a Series B funding round led by Abbott as it expands from quantum sensing into quantum computing technology...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1137Regulatory Approvals1016Innovation655Clinical Trials521Mergers & Acquisitions506GS Funding Tracker49